Credit Agricole
INDV icon

Credit Agricole’s Indivior Pharmaceuticals INDV Stock Holding History

Credit Agricole’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.72M Buy
90,600
+45,042
+99% +$1.63M 0.01% 798
2026
Q1 		$1.39M Hold
45,558
– – ﹤0.01% 998
2025
Q4 		$1.63M Buy
+45,558
New +$1.39M ﹤0.01% 919
2025
Q1 		$8.08M Hold
848,202
– – 0.03% 431
2024
Q4 		$10.5M Hold
848,202
– – 0.03% 372
2024
Q3 		$8.27M Sell
848,202
-2,319
-0.3% -$27.2K 0.04% 327
2024
Q2 		$13.7M Buy
850,521
+5,725
+0.7% +$103K 0.07% 192
2024
Q1 		$15.8M Sell
844,796
-111,381
-12% -$2.09M 0.17% 102
2023
Q4 		$14.6M Buy
956,177
+8
+0% +$142 0.17% 103
2023
Q3 		$22.1M Buy
+956,169
New +$21.8M 0.36% 59

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Credit Agricole's INDV Position: Q2 2026 in Review

Credit Agricole increased its Indivior Pharmaceuticals (INDV) stake by 99% in Q2 2026, buying an estimated $1.63M and bringing the position to 90,600 shares worth $3.72M. The position accounts for 0.01% of the portfolio, ranked #798.

Credit Agricole first reported a position in INDV in Q3 2023 and has held it in 10 quarters since. The position peaked at $22.1M in Q3 2023. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Credit Agricole held 90,600 shares of Indivior Pharmaceuticals worth $3.72M as of Q2 2026.
  • Credit Agricole bought 45,042 Indivior Pharmaceuticals shares in Q2 2026, an estimated $1.63M.
  • Indivior Pharmaceuticals made up 0.01% of Credit Agricole's portfolio in Q2 2026, its #798 holding.
  • Credit Agricole first reported a position in Indivior Pharmaceuticals in Q3 2023 and has held it in 10 quarters since.
  • Credit Agricole's Indivior Pharmaceuticals position peaked at $22.1M in Q3 2023.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.